Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
|Articles|October 27, 1999

Analogic’s Q4, fiscal 1999, results slip

Continued weakness in the Asian and South American markets helped bring in disappointing financial results for Analogic in its fiscal 1999 (end-July). Sales for the year were $279.7 million, down 10.8% from 1998’s $294.5 million, while annual net

Continued weakness in the Asian and South American markets helped bring in disappointing financial results for Analogic in its fiscal 1999 (end-July). Sales for the year were $279.7 million, down 10.8% from 1998’s $294.5 million, while annual net income was $19.5 million, compared with $23.9 million in the same period in 1998.

In the fourth quarter, Analogic had sales of $69 million, down 15.3% from the previous year’s $81.5 million. The Peabody, MA-based company’s net income for the quarter was $3.9 million, compared with $7.2 million in the fourth quarter of 1998. In addition to softness in the Asian and South American markets, Analogic also pointed to costs it sustained for new engineering projects, for start-ups, and to ensure Y2K compliance for its products.

Related to this article

Emerging Research Insights and New Advances in Neuroradiology
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Current Perspectives on Integrating AI into Radiology
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.